{
    "nctId": "NCT04368702",
    "briefTitle": "CONFIRM: Magnetic Resonance Guided Radiation Therapy",
    "officialTitle": "Clinical Onboard Utilization of Image Guided Radiation Therapy With Magnetic Resonance (CONFIRM): A Master Protocol",
    "overallStatus": "RECRUITING",
    "conditions": "Gastric Cancer, Invasive Breast Cancer, in Situ Breast Cancer, Mantle Cell Lymphoma, Larynx Cancer, Bladder Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 70,
    "primaryOutcomeMeasure": "Number of Patients and delivering MR-image guided radiation-Phase I",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants must have histologically or cytologically confirmed malignancy requiring radiation\n* Age 18 years of older\n* ECOG performance status \u22642 (Karnofsky \u226560%, see Appendix A)\n* Ability to understand and the willingness to sign a written informed consent document.\n* Any further criteria listed in the specific disease site cohort\n\nExclusion Criteria\n\n* History of allergic reactions attributed to gadolinium-based IV contrast\n\n  -- Note: If patient will not receive contrast, this is not applicable and kidney function will not affect eligibility\n* Severe claustrophobia or anxiety\n* Participants who cannot undergo an MRI\n* Any other exclusion criteria listed in the specific disease site cohort",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}